BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7688463)

  • 1. Keratin intermediate filament expression in astrocytic neoplasms: analysis by immunocytochemistry, western blot, and northern hybridization.
    Cosgrove MM; Rich KA; Kunin SA; Sherrod AE; Martin SE
    Mod Pathol; 1993 May; 6(3):342-7. PubMed ID: 7688463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cytokeratins in gliomas.
    Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of GFAP, vimentin and cytokeratins in GL-15 glioblastoma cell line.
    Perzelcová A; Máciková ; Tardy M; Mráz P; Steno J; Bízik I
    Neoplasma; 2000; 47(6):362-6. PubMed ID: 11263860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillary acidic protein expression in pleomorphic adenoma, chordoma, and astrocytoma. A comparison of three antibodies.
    Wittchow R; Landas SK
    Arch Pathol Lab Med; 1991 Oct; 115(10):1030-3. PubMed ID: 1654872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 expression in astrocytic tumors.
    Ylagan LR; Quinn B
    Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediate filament expression in astrocytic neoplasms.
    Cosgrove M; Fitzgibbons PL; Sherrod A; Chandrasoma PT; Martin SE
    Am J Surg Pathol; 1989 Feb; 13(2):141-5. PubMed ID: 2464954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
    Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
    Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical study of S-phase cells in human gliomas].
    Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
    No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 17 allelic loss in astrocytic tumors and its clinico-pathologic implications.
    Muhammad AK; Yoshimine T; Maruno M; Tokiyoshi K; Takemoto O; Ninomiya H; Hayakawa T
    Clin Neuropathol; 1997; 16(4):220-6. PubMed ID: 9266149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin immunoreactivity in malignant fibrous histiocytoma and spindle cell tumors: comparison between frozen and paraffin-embedded tissues.
    Litzky LA; Brooks JJ
    Mod Pathol; 1992 Jan; 5(1):30-4. PubMed ID: 1371872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and release of CD14 in astrocytic brain tumors.
    Deininger MH; Meyermann R; Schluesener HJ
    Acta Neuropathol; 2003 Sep; 106(3):271-7. PubMed ID: 12835948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing.
    Johnson TL; Zarbo RJ; Lloyd RV; Crissman JD
    Mod Pathol; 1988 May; 1(3):216-23. PubMed ID: 2467285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity.
    Abaza MS; Shaban F; Narayan RK; Atassi MZ
    Anticancer Res; 1998; 18(2B):1333-40. PubMed ID: 9615812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical and prognostic analysis of cytokeratin expression in malignant uveal melanoma.
    Fuchs U; Kivelä T; Summanen P; Immonen I; Tarkkanen A
    Am J Pathol; 1992 Jul; 141(1):169-81. PubMed ID: 1378696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cells of the lamprey nervous system contain keratin-like proteins.
    Merrick SE; Pleasure SJ; Lurie DI; Pijak DS; Selzer ME; Lee VM
    J Comp Neurol; 1995 May; 355(2):199-210. PubMed ID: 7541809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.